Search results
U.S. to start offering COVID-19 vaccine booster doses in September
AOL· 1 day agoThe White House is prepared to offer a third booster shot starting on that date to all Americans who...
Pfizer’s first gene therapy gets approval for clotting disorder
San Francisco Chronicle· 3 days agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business. The treatment, called Beqvez ...
Biodexa gains license for polyposis asset as stock more than doubles
Pharmaceutical Technology via Yahoo Finance· 6 hours agoIn the trial, thirty patients with FAP who are undergoing endoscopic surveillance will be given...
New studies point to safety of COVID vaccines, but leave questions unanswered
KARE 11 Minneapolis-St. Paul· 5 days ago“I felt like I was dying,” said Norkus. Two days following a booster dose of the Pfizer COVID-19...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 14 hours agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 4 days agoThe study confirmed the vaccine's effectiveness and its importance to control of the disease, while...
We May Be Facing an Epidemic of This Brain Disease
Mercola· 15 hours agoAccording to mounting data, one of the more serious side effects of the COVID mRNA jabs appears to be dementia, and worse yet, this previously untransmissible disease may now be “contagious, ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
Cancer breakthrough as scientists develop jab that could provide miracle cure
Daily Express· 4 days agoA revolutionary skin cancer vaccine being tested on British patients offers hope of a cure for the...
Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc. (Fed. Cir. 2024) | JD Supra
JD Supra· 5 days agoPharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc. The majority opinion raises issues in its invalidity analysis regarding the extent to which the prior art should be required to disclose ...